Page last updated: 2024-08-25

panaxatriol and ginsenoside re

panaxatriol has been researched along with ginsenoside re in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kim, JH; Kim, Y; Madhi, I; Shin, JE	1

Other Studies

1 other study(ies) available for panaxatriol and ginsenoside re

Article	Year
Ginsenoside Re exhibits neuroprotective effects by inhibiting neuroinflammation via CAMK/MAPK/NF‑κB signaling in microglia. Molecular medicine reports, 2021, Volume: 24, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Calcium-Calmodulin-Dependent Protein Kinases; Cell Death; Cytokines; Ginsenosides; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred ICR; Microglia; Mitogen-Activated Protein Kinase Kinases; Neuroinflammatory Diseases; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Signal Transduction; Tumor Necrosis Factor-alpha	2021

Article

Year

Ginsenoside Re exhibits neuroprotective effects by inhibiting neuroinflammation via CAMK/MAPK/NF‑κB signaling in microglia.

Molecular medicine reports, 2021, Volume: 24, Issue:4

Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Calcium-Calmodulin-Dependent Protein Kinases; Cell Death; Cytokines; Ginsenosides; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred ICR; Microglia; Mitogen-Activated Protein Kinase Kinases; Neuroinflammatory Diseases; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Signal Transduction; Tumor Necrosis Factor-alpha

2021